Moreover, LINC-ROR silencing results in the inhibition of cell proliferation, invasion, and EMT through reducing CDH1 expression and increasing the expression of ZEB1/2 and Vimentin in ESCC tumor tissues[26,47]. This evidence concerns the gene CDH1 and esophageal squamous cell carcinoma.